April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
Apple’s Technical Climb To $240 By Year-End
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Oramed Pharmaceuticals (ORMP) Stock Forecast for 2024–2028. Sell or Buy?
Updated: March 18, 2024 (10:50)
Sector: HealthcareThe share price of Oramed Pharmaceuticals Inc. (ORMP) now
50/200 Day Moving Average: $2.943 / $2.705
This figure corresponds to the Average Price over the previous 50/200 days. For Oramed Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Oramed Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Oramed Pharmaceuticals share be worth in 2024 - 2028?
When should I take profit in Oramed Pharmaceuticals stock? When should I record a loss on Oramed Pharmaceuticals stock? What are analysts' forecasts for Oramed Pharmaceuticals stock? What is the future of Oramed Pharmaceuticals stock? We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on Oramed Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Oramed Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Oramed Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Oramed Pharmaceuticals stock
The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Oramed Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Oramed Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 08 | 2.22 | 2.19 | 2.27 | 3.82 |
| May 09 | 2.26 | 2.25 | 2.30 | 2.30 |
| May 10 | 2.28 | 2.23 | 2.33 | 4.07 |
| May 11 | 2.31 | 2.26 | 2.37 | 4.91 |
| May 12 | 2.29 | 2.25 | 2.33 | 3.67 |
| May 13 | 2.28 | 2.26 | 2.32 | 2.71 |
| May 14 | 2.31 | 2.28 | 2.36 | 3.49 |
| May 15 | 2.35 | 2.31 | 2.39 | 3.54 |
| May 16 | 2.31 | 2.28 | 2.37 | 4.18 |
| May 17 | 2.34 | 2.29 | 2.38 | 3.87 |
| May 18 | 2.34 | 2.31 | 2.40 | 3.61 |
| May 19 | 2.33 | 2.30 | 2.37 | 3.04 |
| May 20 | 2.30 | 2.25 | 2.36 | 5.16 |
| May 21 | 2.29 | 2.22 | 2.33 | 4.74 |
| May 22 | 2.25 | 2.18 | 2.29 | 5.03 |
| May 23 | 2.33 | 2.31 | 2.39 | 3.60 |
| May 24 | 2.36 | 2.33 | 2.40 | 3.24 |
| May 25 | 2.35 | 2.28 | 2.42 | 5.89 |
| May 26 | 2.30 | 2.27 | 2.36 | 3.72 |
| May 27 | 2.24 | 2.22 | 2.30 | 3.96 |
| May 28 | 2.24 | 2.17 | 2.28 | 4.75 |
| May 29 | 2.27 | 2.24 | 2.32 | 3.57 |
| May 30 | 2.25 | 2.22 | 2.31 | 4.21 |
| May 31 | 2.22 | 2.19 | 2.24 | 2.18 |
| Jun 01 | 2.17 | 2.13 | 2.23 | 4.40 |
| Jun 02 | 2.25 | 2.23 | 2.32 | 4.09 |
| Jun 03 | 2.23 | 2.17 | 2.28 | 5.10 |
| Jun 04 | 2.14 | 2.07 | 2.16 | 4.21 |
| Jun 05 | 2.12 | 2.09 | 2.17 | 3.73 |
| Jun 06 | 2.03 | 1.98 | 2.09 | 5.71 |
Oramed Pharmaceuticals Daily Price Targets
Oramed Pharmaceuticals Stock Forecast 05-08-2023.
Forecast target price for 05-08-2023: $2.22.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.678%.
Pessimistic target level: 2.19
Optimistic target level: 2.27
Oramed Pharmaceuticals Stock Forecast 05-09-2023.
Forecast target price for 05-09-2023: $2.26.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.247%.
Pessimistic target level: 2.25
Optimistic target level: 2.30
Oramed Pharmaceuticals Stock Forecast 05-10-2023.
Forecast target price for 05-10-2023: $2.28.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.915%.
Pessimistic target level: 2.23
Optimistic target level: 2.33
Oramed Pharmaceuticals Stock Forecast 05-11-2023.
Forecast target price for 05-11-2023: $2.31.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 4.677%.
Pessimistic target level: 2.26
Optimistic target level: 2.37
Oramed Pharmaceuticals Stock Forecast 05-12-2023.
Forecast target price for 05-12-2023: $2.29.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.543%.
Pessimistic target level: 2.25
Optimistic target level: 2.33
Oramed Pharmaceuticals Stock Forecast 05-13-2023.
Forecast target price for 05-13-2023: $2.28.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.636%.
Pessimistic target level: 2.26
Optimistic target level: 2.32
ORMP (ORMP) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 2.27 | 2.11 | 2.46 | 14.37 |
| Jun. | 2.17 | 2.03 | 2.39 | 15.36 |
| Jul. | 2.30 | 2.19 | 2.52 | 13.04 |
| Aug. | 2.22 | 1.98 | 2.31 | 14.02 |
| Sep. | 2.00 | 1.88 | 2.24 | 15.96 |
| Oct. | 1.87 | 1.79 | 2.06 | 13.19 |
| Nov. | 2.12 | 2.04 | 2.19 | 7.11 |
| Dec. | 2.27 | 2.08 | 2.54 | 18.21 |
Oramed Pharmaceuticals forecast for this year
Oramed Pharmaceuticals Stock Prediction for May 2024
An uptrend is forecast for this month with an optimal target price of $2.26502. Pessimistic: $2.11. Optimistic: $2.46
Oramed Pharmaceuticals Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $2.16989. Pessimistic: $2.03. Optimistic: $2.39
Oramed Pharmaceuticals Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $2.30334. Pessimistic: $2.19. Optimistic: $2.52
Oramed Pharmaceuticals Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $2.22387. Pessimistic: $1.98. Optimistic: $2.31
Oramed Pharmaceuticals Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $2.00371. Pessimistic: $1.88. Optimistic: $2.24
Oramed Pharmaceuticals Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $1.86545. Pessimistic: $1.79. Optimistic: $2.06
Oramed Pharmaceuticals Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $2.12009. Pessimistic: $2.04. Optimistic: $2.19
Oramed Pharmaceuticals Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $2.26637. Pessimistic: $2.08. Optimistic: $2.54
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.35 | 2.18 | 2.44 | 10.84 |
| Feb | 2.55 | 2.46 | 2.70 | 8.77 |
| Mar | 2.19 | 2.01 | 2.28 | 11.91 |
| Apr | 2.34 | 2.15 | 2.50 | 14.03 |
| May | 2.41 | 2.34 | 2.56 | 8.76 |
| Jun | 2.33 | 2.05 | 2.57 | 20.04 |
| Jul | 2.19 | 2.02 | 2.36 | 14.33 |
| Aug | 2.35 | 2.22 | 2.55 | 12.87 |
| Sep | 2.59 | 2.49 | 2.73 | 8.97 |
| Oct | 2.81 | 2.70 | 2.97 | 9.08 |
| Nov | 3.22 | 3.03 | 3.39 | 10.67 |
| Dec | 3.22 | 3.00 | 3.34 | 10.28 |
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.11 | 3.01 | 3.40 | 11.53 |
| Feb | 3.19 | 2.99 | 3.46 | 13.54 |
| Mar | 3.05 | 2.81 | 3.18 | 11.79 |
| Apr | 2.85 | 2.57 | 3.11 | 17.45 |
| May | 2.81 | 2.72 | 2.94 | 7.31 |
| Jun | 3.20 | 3.01 | 3.37 | 10.69 |
| Jul | 3.23 | 3.14 | 3.38 | 7.31 |
| Aug | 3.19 | 3.03 | 3.45 | 12.21 |
| Sep | 2.99 | 2.88 | 3.28 | 12.44 |
| Oct | 2.94 | 2.67 | 3.21 | 16.74 |
| Nov | 2.81 | 2.49 | 2.98 | 16.27 |
| Dec | 2.77 | 2.60 | 2.92 | 10.82 |
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.85 | 2.60 | 3.11 | 16.38 |
| Feb | 2.69 | 2.52 | 2.79 | 9.71 |
| Mar | 2.51 | 2.39 | 2.60 | 8.11 |
| Apr | 2.41 | 2.32 | 2.69 | 13.60 |
| May | 2.69 | 2.48 | 2.97 | 16.54 |
| Jun | 2.60 | 2.31 | 2.70 | 14.56 |
| Jul | 2.58 | 2.36 | 2.86 | 17.55 |
| Aug | 2.57 | 2.41 | 2.85 | 15.55 |
| Sep | 2.24 | 2.15 | 2.51 | 14.46 |
| Oct | 2.07 | 1.93 | 2.24 | 13.62 |
| Nov | 2.09 | 1.90 | 2.30 | 17.31 |
| Dec | 1.99 | 1.87 | 2.09 | 10.43 |
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.22 | 2.11 | 2.32 | 9.30 |
| Feb | 2.13 | 1.89 | 2.24 | 15.82 |
| Mar | 1.97 | 1.77 | 2.09 | 15.04 |
| Apr | 2.11 | 2.01 | 2.19 | 8.37 |
| May | 2.27 | 2.08 | 2.35 | 11.58 |
| Jun | 2.45 | 2.35 | 2.66 | 11.62 |
| Jul | 2.37 | 2.16 | 2.62 | 17.60 |
| Aug | 2.43 | 2.23 | 2.57 | 13.07 |
| Sep | 2.52 | 2.33 | 2.68 | 13.12 |
| Oct | 2.63 | 2.42 | 2.81 | 13.75 |
| Nov | 2.63 | 2.32 | 2.73 | 14.91 |
| Dec | 2.65 | 2.34 | 2.80 | 16.49 |
Oramed Pharmaceuticals information and performance
HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL
Market capitalization of the Oramed Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ORMP shares in the company outstanding by the market price of one share.
EBITDA of Oramed Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
